Asahi Kasei Pharma Corporation — China drug registrations and re-registration deadlines
8 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-10-28.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20171046 | Elcitonin 依降钙素注射液 | 2027-04-28 | 2026-10-28 |
| 国药准字HJ20171234 | Exacin 硫酸异帕米星注射液 | 2027-08-30 | 2027-02-28 |
| 国药准字HJ20171235 | Exacin 硫酸异帕米星注射液 | 2027-08-30 | 2027-02-28 |
| 国药准字HJ20140243 | Bredinin 咪唑立宾片 | 2029-09-23 | 2029-03-23 |
| 国药准字HJ20140244 | Bredinin 咪唑立宾片 | 2029-09-23 | 2029-03-23 |
| 国药准字HJ20150252 | Eril 盐酸法舒地尔注射液 | 2030-03-18 | 2029-09-18 |
| 国药准字HJ20200016 | Flivas 萘哌地尔片 | 2030-04-14 | 2029-10-14 |
| 国药准字HJ20200017 | Flivas 萘哌地尔片 | 2030-04-14 | 2029-10-14 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.